劉宇隆:日均接種30萬劑疫苗雖匪夷所思 但有計劃必定做到
《商業電臺》報道,對於港大感染及傳染病中心總監何(柏)良指,本港要加快疫苗接種速度,至平均每日30萬劑,疫苗可預防疾病科學委員會主席、香港大學兒童及青少年科學系講座教授劉宇隆認爲,該建議雖然聽起來匪夷所思,但其實只要有計劃和籌謀,是一定做得到。
劉宇隆表示,他已呼籲政府邀請不同的醫學團體及私家醫生,參與外展接種工作,爲兒童及長者接種新冠疫苗。另提醒,只要子女之前接種過採用滅活平臺的季節性流感疫苗,基本上都可接種新冠疫苗。雖然0至3歲幼童未納入接種對象,但幼童的照顧者應該全部接種疫苗,降低他們感染的風險,即使受感染,病毒量都會下降得較快,有助提升對幼童的保護。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.